•••

Dr. Reddy's �;•

July 30, 2020

To,

The Secretary

BSE Limited

National Stock Exchange oflndia Limited

Dear Sir/Madam,

Dr. Raddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN: L85195TG1984PLC004507

Tel

:+91 40 4900 2900

Fax

:+91 40 4900 2999

Email :mail@drreddys.com www.drreddys.com

Sub: Newspaper advertisement regarding financial results ofQl FY2021

Pursuant to Regulation 47 ofthe Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed copies of newspaper advertisement regarding the financial results ofthe company for the quarter ended June 30, 2020 as published in Business Standard and Andhra Prabha on July 30, 2020.

This is for your information and records.

With regards,

. .

Sar Po ar omp' Secretary

r

Place :

Chennai

r

P.Dinakara Babu

Date :

28.07.2020

Company Secretary

Business Standard - July 30, 2020

Dr.Reddy's t'

SI.

No.

1

2

3

4

5

6

7

8

Extract of unaudited flnanclal results of Dr. Reddy's Laboratories Limited and Its subsidiaries for the quarter

ended 30 June 2020 prepared In compliance with Indian Accounting Standards

All amounts in Indian Rupees millions

Quarter

Consolidated

Year

Quarter

Particulars

ended

ended

ended

30.06.2020

31.03.2020

30.06.2019

(Unaudited)

(Audited)

(Unaudited)

Total Income from Operations

44,265

175,170

38,582

Net Profit for the period (before Tax, Exceptional and/or Extraordinary items)

9,005

18,857

8,693

Net Profit for the period before tax (after Exceptional and/or Extraordinary items)

9,005

18,857

8,693

Net Profit for the period after tax (after Exceptional and/or Extraordinary items)

5,946

20,260

6,765

Total Comprehensive Income for the period

6,728

19,610

6,472

Equity Share Capital

831

831

831

Reserves (excluding Revaluation Reserve)

155,157

Earnings per share (In Rupees) per Rs. Si• share

35.87

122.22

40.81

Basic

Diluted

35.78

121.99

40.74

SI.

No.Particulars

  • Total Income from Operations
  • Net Profit for the period (before Tax, Exceptional and/or Extr.1ordinary items)
  • Net Profit for the period before tax (after Exceptional and/or Extraordinary items)
    4 Net Profit for the period after tax (after Exceptional and/or Extraordinary items) 5 Total Comprehensive Income for the period
    6 Equity Share Capital
    7 Reserves (excluding Revaluation Reserve)
    8 Earnings per share (In Rupees) per Rs. 5/· share Basic
    Diluted
    Notes:

Quarter

Standalone

Year

Quarter

ended

ended

ended

30.06.2020

31.03.2020

30.06.2019

(Unaudited)

(Audited)

(Unaudited)

32,444

118,504

25,087

13,617

27,758

6,930

13,617

27,758

6,930

9,502

29,377

5,481

9,733

28,941

5,441

831

831

831

151,088

57.31

177.23

33.06

57.18

176.88

33.01

  • The above is an extract of the detailed 1ormat of Quarterly Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly Financial Results are available on the Stock Exchanges website: www.bseindia.com and www.nseindia.com and also on the Company's website: www.drreddys.com.
  • The unaudited resutts have been reviewed by the Audit Committee of the Board and approved by the Board of Directors of the Company at their meeting held on 29July 2020.

By order of the Board For Dr. Raddy's Laboratories Limited

Place : Hyderabad

Date : 29July 2020G V Prasad Co-Chairman & Managing Direcor

Dr. REDDY'S LABORATORIES LIMITED

Regd. Office: 8 -2-337, Road No.3, Banjara HIiis, Hyderabad• 500 034, Telangana, India

CIN: L8 5195TG1984PLC004507, Tel: 91404900 2900, Fax: 91404900 2999 email: shares@drreddys.com, website: www.drreddys.com

n®�Pa,milta,a@,/11,a,

Rail Vikas Nigam Limited

(A Government of India Enterprise)

RAIL VIKAS NIGAM LIMITED

(A Govt. of India Enterprise)

office: 1st Floor, August Kranti Bhawan, Bhlkajl Cama Place, R. K. Puram, New Delhi, South Delhi -110066E-mail:investors@rvnl.orgWebsite:www.rvnl.org;CIN:L74999DL2003G01118633

,ONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED ON MARCH 31, 2020

Standalone

(, II llldlsuce,t EPS)

Quarter Ended

Consolidated

31.03.2020

Year

Ended

Quarter Ended

Year

Ended

31.12.2019

31.03.2019

31.03.2020

31.03.2019

31.03.2020

31.12.2019

31.03.2019

31.03.2020

31.03.2019

(Unaudited)

(Unaudited)

(Unaudited)

(Audlled)

(Audited)

(Unaudited)

(Unaudited)

(UnaudHedJ

(AudHedJ

(Audited)

4,22,067.49

3,69,926.50

3,41,844.49

14,53,057.97

10,06,007.06

4,22,067.49

3,69,926.50

3,42,705.56

14,53,057.97

10,06,868.13

5 657.92

7 385.76

6 219.09

26 557.86

27 263.21

5 661.33

7 387.34

6 221.86

24 568.45

25 524.19

4 27 725.41

3 77 312.26

3 48 063.58 14 79,615.83

1D,33 270.27

4 27 728.82

3,77,313.84

3,48,927.42

14,77,626.42

10 32 392.32

24,875.07

27,986.63

22,815.32

99,084.03

75,831.26

29,879.23

18,541.32

23,371.22

95,431.66

83,948.26

19,730.31

19,793.60

18,583.91

78,985.97

60,658.65

24,734.15

10,348.15

19,139.78

75,332.27

68,774.35

(loss)

1,242.35

1,242.35

1,242.35

1,242.35

-161.95

-32.04

-154.36

-204.95

-154.16

-161.27

-32.03

-154.36

-204.27

-154:02

208502.01

,

_ 208502.01

208502.0L.. 208502.01

208502.01

,-1Q!!.502.Q1

208502.01

208502.01

208502.01 _ 208502.Q.1

���- Eks-6��2��of�atitie

'urr•-�·-----

�s:..aw:i.:a:;

-

- ......

rnwt-

;I

J

221009e6

2S.08.2020 ....t :,,olr •�140 l�� •ISA�L

70 �-.,, 163060/-

JOSe>� d)t,

!!ici�

�w"6S

�o�

CompanyWill beheld on Thursday the 13

�.:>

526001-

August 2020

P.M

111

22201004 2s.oa.2020

�,s 3/4"

•IS4.:l�L

1990ao.w

·r,

at 03.30

at the Registered

so�; ;;- a��_,- ��:)

•IS4.):SO.

19 �o.w

7541/fJ/-

�6�� .sM a�. :sf;,:JQoSe>�

S

ll19092◄F

25.08.2020

t,)

Office ofthe Company to apProve and take

.� �w"6S 1196:itll !!ioSJ-oe, �o�

for lhe Quarter ended 30111

June 2020.

"'.

6

22191011

26.08.2020

.,.1r,6e rro�5 �.:>

•IS4.):SL

0

61060/,-

'o�� �6��. oe.xiru �.:J:O�oSJ-o�

on record the Unaudited Financial Resulls

273 � ..,,

For BKV INDUSTRIES LIMITED

CPROtS-16

�:l.)�.,. .:i� ��o�e.:i ��.IS. .,,.� ��s- rf6'6tJ-5

; a�. omru 1!9��tx, :i!os'e

Sd/· B. Viral Vishnu

f>r,

29.07.2020

Compliance Officer .

�.,., e-io-io-.

;:,0..,1>0.:i :lll:i :.0-11:Sic>.:.

�e

:io. 097948-4595�

�:s

�.:ll!Cllll.

__

GUNTUR

Company SecMtary &

·Ell

,

Andhra Prabha - July 30, 2020

Dr.Reddys ,.-.

.,.,.j,

Extract of unaudited financial results of Dr. Reddy's Laboratories Limited and Its aubsJdfarles for the quarter

ended 30 June 2020 prepared In compliance with Indian Accounting Standards

el

All amounts in Indian R•mAes millions·�

!'->

consouoatea

w

SI.

Quarter

Vear

Quarter

"'

Partlcufars

ended

ended

ended

No.

30.06.2020

31.03.2020

30.06.2019, b5"

(Unaudited)

(Audited)

(Unaudltedf

1

Total Income from Operations

44.265

175,170

38.582

,.,

2

Net Profit for lhe pertod (before Tax, Ex<:eptional and/or Extraordinary Items)

9,005

18,857

8.693:

3

Net Profit for the perlod before tax (after Exceptional and/or Extraordinary Items}

9.005

18,857

8,693

":;'3

4

Net Profit for the period alter tax (after Exceptional and/or Extraordinary items}

5,946

20,260

6,765

5

Total COmprehensiVe Income for the period

6.728

19,610

6,472

I

6

Equity Share Capital

831

831

631

l3ti

7

Reserves (excluding Revaluation Reserve}

155,157

8

Eemlngs per ehare (In Rupees) per Rs,. 5/• share

35.87

122.22

40.81 'b°b

Basic

Diluted

35,78

121.99

40,74

·"

Quarter

Standalone

Quarter

:'.A

SI.

Year

No.

Particulars

ended

ended

ended

-

-�

30.06.2020

31.03.2020

30.06.2019

L,f:

1

Total Income from Operations

(Unaudited)

(Audited}

(Unaudited)

.,,

32,444

118,504

25,087

:!!I

2

Net Profit for the period (before Tax, Exceptional and/or E.xttaordlnary items)

13,617

27,758

6,930.

3

Net Proflt for the period before tax (after Exceptional and/or Extraordinary items)

13,617

27,758

6,930

'�

4

Net Profit for the period after tax (after Exceptional and/or E�ordinary items)

9,502

29,377

5,481

5

Total Comprehensive Income for the period

9,733

28,941

5 441

,

'::I

6

Equity Share Capital

831

831

,831

7

Reserves (excluding Revaluation Reserve)

151.088

,

8

Eamlnge per share (In Rupees) per Re

51· share

57.31

1n.23

33 06

Baslc

.

..

.:a:....Notes: '"'

DUuted

-

·

,. � -

·•

- 0

57.18

17'",.,, l

..-..nt

-

-

·-:-

�,._

1

The above is an extract of thedetailed format of Quarterly Financial Results filed with theStock Exchanges under Regulation 33 ot the SEBI (Listing

I

and Other Disclosure Requirements) Regulations, 2015. The full format or the Ouanedy Financial Results are available on the Stock Exchanges

2

website: www.bseindia.com aod www.nseindia.com and also on the Company's website: www.drreddys.com.

The unaudited results have been reliewed by theAudit Committee of the Board and approved by the Board of Directors of the Company at their

meeting held on 29 July 2020.

By order of the Board

Place

:

Hyderabad

For Dr. Raddy's Laboratories Limited

GV Prasad

Date

:

29 July2020

Co-Chairman & Managing Dir8(:()r

,·-:""'

Dr. REDDY'S LABORATORIES LIMITED

Regd. Office: 8-2-337, Road No.3, BanJara HIii,

Hy erabad• 500 034, Tetangana, India

i•t,•

i'.

s

d

CIN: L85195TG1984PLC004507, Tel: 91 40 4900 2900, Fax: 91 40 4900 2999

,'

;�..,

a

ste

.

d

co

m

.

.____________em 11:_s_hares_...,@drreddys.co_m_,_we1 b_:_www rreddy•_.

_, _,1�

---------------------------------------------+•,';.w

';,eO;j&" �QJ ���Q

C)d�: 6-3-541/ib.��-500 082.

PLC014332 • www.haritagefoods.in - Tai; 040 - 2�391221/23391222 Fax: 30685458, Email- hfl@herltagefoods.in

���-1o-&t6� �do'salO� sa&>�i��

:it.- 60 ��;s

�Ai 6or:l

•06�� �� �QQ)

eiocS�O,,,� �� ';,�Q)

,.- ' ��.)� ���Ii

30-06-202031-03-2020

30-06-2019

31-03-202030-06-2020 31-03-2020

(•4.r r:>)

(es&tS" ��;S)

{e:s�tS" S"�)

<•e.Ar ��;:,)

(veter Ir�)

(es�cS" ��;S)

70728.77

79132.97

76008.47

302926.04

68826.38

78135.56

lOI'.>)

10551.22

(20692.51)

2981.51

(15405.42)

10287.54

(20739,53)

�)

10551.22

(20692.51)

2981.51

(15405.42)

10287.54

(20739.53)

9544.23

(20989.47)

1810.03

(16940.02)

9395.58

(21033.04)

.... ---.t

44711::J ,f?

/�')7')g i:;,Q

?DA'> ?".I

#'LI IU�A '21\

"•a◄o1 117

/'2'>7&H> ,:,1

30-06-2019

{e:s�cS"S"'�)

74964.70

3327.31

3327.31

2171.34

"l"lA"'l £'2

31-03-2020i

(.e..r ��:S) ,c- 298391.89''"'°'�11I

(14467.64) :t)i_" I

{14467.64) "ti I (16000.44) "'...(:-::i

1"2'14-4 t: ft�

Attachments

  • Original document
  • Permalink

Disclaimer

Dr. Reddy's Laboratories Limited published this content on 30 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 August 2020 00:06:18 UTC